Amount Raised
$10.5 Million
Round Type
Funding Round
StrasbourgBiotechnologyHealth CareDescription
Core Biogenesis, an emerging biotechnology company with a novel plant-based bioproduction platform, recently completed a $10.5M Series A funding round. The funds will be used to build out an industrial scale facility dedicated to producing growth factors and cytokines for the burgeoning cell therapy market and cellular agriculture industry, and to hire additional scientific and technical staff to support the expansion. The funding round was led by XAnge, a Paris-based science and technology venture capital firm. Other investors include Blue Horizon Ventures, a Zurich-based venture capital firm with a focus on protein alternatives and food tech, and Thia Ventures, an investor at the crossroads of biotechnology, nutrition and health, with offices in Geneva, Luxembourg, Belgium and Singapore.
Quick answer
Core Biogenesis raised $10.5 Million in a Funding Round round, dated July 28, 2022. Core Biogenesis is based in Strasbourg, Grand Est, France.
- How much did Core Biogenesis raise?
- Core Biogenesis raised $10.5 Million in a Funding Round round on July 28, 2022.
- What does Core Biogenesis do?
- Founded in May 2020 by Dr. Chouaib Meziadi and Alexandre Reeber, Core Biogenesis employs a novel green bioproduction platform to express recombinant proteins from plants.
- Where is Core Biogenesis based and how big is it?
- Core Biogenesis is based in Strasbourg, Grand Est, France.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Core Biogenesis that raised within 45 days of this round, from Fundz verified event records.
- Novabay raised $2.1M (Seed) on September 9, 2022.
- ABK Biomedical raised $18M on September 9, 2022.
- Novabay raised $5.3M (Post-IPO Equity) on September 9, 2022.
- Tetra Bio-Pharma Inc. raised an undisclosed amount (Funding Round) on September 8, 2022.
- Photys Therapeutics raised $75M (Series A) on September 8, 2022.
- Nutromics raised $14M (Funding Round) on September 8, 2022.
Who to call at Core Biogenesis, and when
A new round usually means Core Biogenesis is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Core Biogenesis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Core Biogenesis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Core Biogenesis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Core Biogenesis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Core Biogenesis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.